Knee Osteoarthritis (Gonarthrosis)
Of all types of osteoarthritis, gonarthrosis—osteoarthritis of the knee—is the most common. This is a disease in which the hyaline (articular) cartilage breaks down and can no longer perform its function. As the condition progresses, other joint components are also destroyed, leading to joint deformity.
Joint replacement surgery may be performed to treat the knee joint and restore mobility. However, at certain stages of osteoarthritis, a less invasive alternative is available: arthro-medullary shunting.
Groups at Risk
Knee osteoarthritis (gonarthrosis) is most common in women over 40. The risk is also high for individuals with excess body weight, high sports loads, old knee injuries, neurological issues, or genetic connective tissue weakness.
This modern therapeutic approach for knee osteoarthritis was developed by researchers at the N.N. Priorov Central Research Institute of Traumatology and Orthopedics.
Following the shunt implantation, components of the patient’s own bone marrow fat enter the joint cavity to exert a therapeutic effect. Because the procedure is minimally invasive, recovery occurs in record time. Within just 24 hours of the procedure, most patients can stand and walk, and within a month, they return to their normal lifestyle.
ndications for knee arthro-medullary shunting:
- Stage I–III gonarthrosis
- Deforming osteoarthritis (OA)
- Post-traumatic osteoarthritis
- König's disease
- Synovitis of specific etiologies, at the discretion of the orthopedic surgeon
- Damage to degeneratively altered menisci
- Healed intra-articular and transchondral fractures
- High body weight where joint replacement is contraindicated
- Prolonged pain syndrome (lasting more than 6 months)
- Waiting period for joint replacement surgery
- Inability or unwillingness to undergo joint replacement surgery
